Literature DB >> 29017078

FGF1 and IGF1-conditioned 3D culture system promoted the amplification and cancer stemness of lung cancer cells.

Pengpeng Liu1, Rui Zhang1, Wenwen Yu2, Yingnan Ye1, Yanan Cheng1, Lei Han1, Li Dong1, Yongzi Chen3, Xiyin Wei4, Jinpu Yu5.   

Abstract

Lung cancer stem cells (LCSCs) are considered as the cellular origins of metastasis and relapse of lung cancer. However, routine two-dimensional culture system (2D-culture) hardly mimics the growth and functions of LCSCs in vivo and therefore significantly decreases the stemness activity of LCSCs. In this study, we constructed a special BME-based three-dimensional culture system (3D-culture) to amplify LCSCs in human lung adenocarcinoma cell line A549 cells and found 3D-culture promoted the enrichment and amplification of LCSCs in A549 cells displaying higher proliferation potential and invasion activity, but lower apoptosis. The expression and secretion levels of FGF1 and IGF1 were dramatically elevated in 3D-culture compared to 2D-culture. After growing in FGF1 and IGF1-conditioned 3D-culture, the proportion of LCSCs with specific stemness phenotypes in A549 cells significantly increased compared to that in conventional 3D suspension culture system. Further results indicated that FGF1 and IGF1 promoted the amplification and cancer stemness of LCSCs dependent on MAPK signaling pathway. Our data firstly established a growth factors-conditioned 3D-culture for LCSCs and demonstrated the effects of FGF1 and IGF1 in promoting the enrichment and amplification of LCSCs which might provide a feasible cell model in vitro for both mechanism study and translational research on lung cancer.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3D culture; Cancer stem cells; FGF1; IGF1; Lung cancer; MAPK signaling

Mesh:

Substances:

Year:  2017        PMID: 29017078     DOI: 10.1016/j.biomaterials.2017.09.030

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  13 in total

1.  MicroRNA-106b-5p (miR-106b-5p) suppresses the proliferation and metastasis of cervical cancer cells via down-regulating fibroblast growth factor 4 (FGF4) expression.

Authors:  Lei Hongwei; Li Juan; Xu Xiaoying; Fan Zhijun
Journal:  Cytotechnology       Date:  2022-06-06       Impact factor: 2.040

2.  BCSCdb: a database of biomarkers of cancer stem cells.

Authors:  Shazia Firdous; Abhirupa Ghosh; Sudipto Saha
Journal:  Database (Oxford)       Date:  2022-09-28       Impact factor: 4.462

3.  FGF1 alleviates LPS-induced acute lung injury via suppression of inflammation and oxidative stress.

Authors:  Qhaweni Dhlamini; Wei Wang; Guifeng Feng; Aiping Chen; Lei Chong; Xue Li; Quan Li; Jin Wu; Depu Zhou; Jie Wang; Hailin Zhang; Jin-San Zhang
Journal:  Mol Med       Date:  2022-06-28       Impact factor: 6.376

Review 4.  MiR-326: Promising Biomarker for Cancer.

Authors:  Yao-Jie Pan; Jian Wan; Chun-Bin Wang
Journal:  Cancer Manag Res       Date:  2019-12-11       Impact factor: 3.989

5.  Identification of a Potentially Functional microRNA-mRNA Regulatory Network in Lung Adenocarcinoma Using a Bioinformatics Analysis.

Authors:  Xiao-Jun Wang; Jing Gao; Zhuo Wang; Qin Yu
Journal:  Front Cell Dev Biol       Date:  2021-02-18

Review 6.  Not Only Immune Escape-The Confusing Role of the TRP Metabolic Pathway in Carcinogenesis.

Authors:  Iwona Kwiatkowska; Justyna Magdalena Hermanowicz; Alicja Przybyszewska-Podstawka; Dariusz Pawlak
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

7.  MiR-186-3p attenuates tumorigenesis of cervical cancer by targeting IGF1.

Authors:  Xiurong Lu; Xiao Song; Xiaohui Hao; Xiaoyu Liu; Xianyu Zhang; Na Yuan; Huan Ma; Zhilin Zhang
Journal:  World J Surg Oncol       Date:  2021-07-12       Impact factor: 2.754

8.  Lin28A promotes the proliferation and stemness of lung cancer cells via the activation of mitogen-activated protein kinase pathway dependent on microRNA let-7c.

Authors:  Rui Zhang; Pengpeng Liu; Xiao Zhang; Yingnan Ye; Jinpu Yu
Journal:  Ann Transl Med       Date:  2021-06

9.  Lung CSC-derived exosomal miR-210-3p contributes to a pro-metastatic phenotype in lung cancer by targeting FGFRL1.

Authors:  Li Wang; Jun He; Haoyue Hu; Li Tu; Zhen Sun; Yanyang Liu; Feng Luo
Journal:  J Cell Mol Med       Date:  2020-05-12       Impact factor: 5.310

10.  Co-delivery of sorafenib and crizotinib encapsulated with polymeric nanoparticles for the treatment of in vivo lung cancer animal model.

Authors:  Tian Zhong; Xingren Liu; Hongmin Li; Jing Zhang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.